AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
Glioblastoma multiforme (GBM) is the most common intracranial malignancy in adults with the highest degree of malignancy and mortality. Due to its nature of diffuse invasiveness and high migration, GBM lacks an effective treatment strategy and is associated with poor prognosis. SC66 is a novel AKT i...
Main Authors: | Lun Gao, Junhui Liu, Pengfei Xu, Gang Deng, Baohui Liu, Fanen Yuan, Yinqiu Tan, Qian Sun, Yang Xu, Huikai Zhang, Yangzhi Qi, Shoumeng Han, Kun Yang, Rongxin Geng, Hongxiang Jiang, Qianxue Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01102/full |
Similar Items
-
Circulating Tumor Cells for Glioma
by: Huikai Zhang, et al.
Published: (2021-03-01) -
Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
by: Yang Xu, et al.
Published: (2021-10-01) -
Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
by: Yong Li, et al.
Published: (2020-01-01) -
RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway
by: Yang Xu, et al.
Published: (2020-08-01) -
Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
by: Yang Xu, et al.
Published: (2019-03-01)